Downregulation of the BK channel beta1 subunit in arteriole myocytes may be a molecular mechanism underlying early vasoconstriction in diabetic retinopathy.
Answers are grounded in this paper and cite their sources.
May link BKβ1 loss to early retinal vasoconstriction in diabetic rats; hypothesis-generating for human translation.
Diabetic retinopathy is an important cause of visual loss. Functional abnormalities including vasoconstriction precede structural changes. Using the streptozotocin-model of diabetes in rats, we have identified downregulation of the beta1 subunit of the BK channel in arteriole myocytes as a possible molecular mechanism underlying these early changes. BKbeta1 mRNA levels were reduced as early as one month after induction of diabetes, and BK Ca(2+)-sensitivity and caffeine-evoked BK currents were reduced at three months. This effect appears to be selective for the regulatory subunit, as BKalpha subunit expression was not altered at the mRNA level, and voltage-activated BK currents were unaltered. No changes were seen in voltage activated Ca(2+)-current, Ca(2+)-activated Cl(-)current, or A-type voltage activated K(+)-currents. Reduced Ca(2+)-activated BK activity may promote depolarization, Ca(2+)-channel activation and increased contraction under resting conditions or in response to Ca(2+)-mobilizing agonists.
No takes yet. Share an insight, caveat, or question.
McGahon et al. (2007) studied Diabetic retinopathy. Streptozotocin-induced diabetes was evaluated on BKbeta1 mRNA levels and BK Ca(2+)-sensitivity.
Synapse has enriched 10 related papers. Consider them for comparative context: